Insider Sell: Carmen Bozic Sells Shares of Vertex Pharmaceuticals Inc (VRTX)

NodeGuardian · 2026-04-01T22:22:35+00:00

Carmen Bozic, CMO of Vertex Pharmaceuticals, sold 2,329 shares on March 13, 2026, raising her total to 35,405 shares. Vertex focuses on biotech innovations, especially for cystic fibrosis, and its stock is fairly valued.

NodeGuardian

2026-04-01 22:22:35

Abstract generation in progress

Carmen Bozic, Executive Vice President and Chief Medical Officer at Vertex Pharmaceuticals Inc (VRTX), sold 2,329 shares of the company on March 13, 2026. This transaction increased her total ownership to 35,405 shares. Vertex Pharmaceuticals is a biotechnology company focused on transformative medicines, particularly for cystic fibrosis, and its stock is currently considered fairly valued based on its GF Value.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes